 | B3Y | Name: | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | Formula: | C10 H13 N O3 | SMILES: | O=C(O)CC(N)Cc1ccc(O)cc1 | InChi: | InChI=1S/C10H13NO3/c11-8(6-10(13)14)5-7-1-3-9(12)4-2-7/h1-4,8,12H,5-6,11H2,(H,13,14)/t8-/m0/s1 | Definition date: | 2007-02-28 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-amino-4-(4-hydroxyphenyl)butanoic acid |
|
 | TUK | Name: | 2-[2-[(1~{S})-1-azanyl-3-methylsulfanyl-propyl]-4-(1~{H}-indol-3-ylmethyl)-5-oxidanylidene-2~{H}-imidazol-1-yl]ethanal | Formula: | C18 H22 N4 O3 S | SMILES: | CSCC[CH](N)[CH]1N=C(Cc2c[nH]c3ccccc23)C(=O)N1CC(O)=O | InChi: | InChI=1S/C18H22N4O3S/c1-26-7-6-13(19)17-21-15(18(25)22(17)10-16(23)24)8-11-9-20-14-5-3-2-4-12(11)14/h2-5,9,13,17,20H,6-8,10,19H2,1H3,(H,23,24)/t13-,17-/m0/s1 | Definition date: | 2021-01-13 | Last modified: | 2024-09-27 | Release date: | 2022-03-02 | Identifier: | 2-[2-[(1~{S})-1-azanyl-3-methylsulfanyl-propyl]-4-(1~{H}-indol-3-ylmethyl)-5-oxidanylidene-2~{H}-imidazol-1-yl]ethanoic acid |
|
 | TUN | Name: | ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE | Formula: | C6 H16 N O3 P | SMILES: | O=P(O)(OCC)N(CC)CC | InChi: | InChI=1S/C6H16NO3P/c1-4-7(5-2)11(8,9)10-6-3/h4-6H2,1-3H3,(H,8,9) | Definition date: | 2009-05-11 | Last modified: | 2024-09-27 | Identifier: | ethyl hydrogen diethylamidophosphate |
|
 | B4H | Name: | N-methylidene-3-nitrobenzamide | Formula: | C8 H6 N2 O3 | SMILES: | O=[N+](c1cc(ccc1)C(=O)N=C)[O-] | InChi: | InChI=1S/C8H6N2O3/c1-9-8(11)6-3-2-4-7(5-6)10(12)13/h2-5H,1H2 | Definition date: | 2015-09-30 | Last modified: | 2024-09-27 | Release date: | 2016-09-21 | Identifier: | N-methylidene-3-nitrobenzamide |
|
 | TVA | Name: | N-[(2R,3S)-3-amino-2-hydroxy-4-(thiophen-2-yl)butyl]-L-norvaline | Formula: | C13 H22 N2 O3 S | SMILES: | O=C(O)C(NCC(O)C(N)Cc1sccc1)CCC | InChi: | InChI=1S/C13H22N2O3S/c1-2-4-11(13(17)18)15-8-12(16)10(14)7-9-5-3-6-19-9/h3,5-6,10-12,15-16H,2,4,7-8,14H2,1H3,(H,17,18)/t10-,11-,12+/m0/s1 | Definition date: | 2014-06-24 | Last modified: | 2024-09-27 | Release date: | 2015-07-01 | Identifier: | N-[(2R,3S)-3-amino-2-hydroxy-4-(thiophen-2-yl)butyl]-L-norvaline |
|
 | TVB | Name: | 4-[[(2~{R})-2-methyl-3,4-dihydro-2~{H}-quinolin-1-yl]sulfonyl]benzaldehyde | Formula: | C17 H17 N O3 S | SMILES: | C[CH]1CCc2ccccc2N1[S](=O)(=O)c3ccc(C=O)cc3 | InChi: | InChI=1S/C17H17NO3S/c1-13-6-9-15-4-2-3-5-17(15)18(13)22(20,21)16-10-7-14(12-19)8-11-16/h2-5,7-8,10-13H,6,9H2,1H3/t13-/m1/s1 | Definition date: | 2021-01-13 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 4-[[(2~{R})-2-methyl-3,4-dihydro-2~{H}-quinolin-1-yl]sulfonyl]benzaldehyde |
|
 | TVE | Name: | (2~{S},3~{R},4~{R})-3-[5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-4-methyl-5-[(2~{S},3~{R})-3-oxidanyl-1-oxidanylidene-butan-2-yl]-3,4-dihydro-2~{H}-pyrrole-2-carboxylic acid | Formula: | C22 H27 N3 O7 S | SMILES: | C[CH](O)[CH](C=O)C1=N[CH]([CH](SC2CNC(C2)C(=O)Nc3cccc(c3)C(O)=O)[CH]1C)C(O)=O | InChi: | InChI=1S/C22H27N3O7S/c1-10-17(15(9-26)11(2)27)25-18(22(31)32)19(10)33-14-7-16(23-8-14)20(28)24-13-5-3-4-12(6-13)21(29)30/h3-6,9-11,14-16,18-19,23,27H,7-8H2,1-2H3,(H,24,28)(H,29,30)(H,31,32)/t10-,11-,14?,15-,16?,18-,19-/m1/s1 | Definition date: | 2021-01-13 | Last modified: | 2024-09-27 | Release date: | 2021-07-21 | Identifier: | (2~{S},3~{R},4~{R})-3-[(5~{S})-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-4-methyl-5-[(2~{S},3~{R})-3-oxidanyl-1-oxidanylidene-butan-2-yl]-3,4-dihydro-2~{H}-pyrrole-2-carboxylic acid |
|
 | B59 | Name: | 1,3-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropteridine-6-carbaldehyde | Formula: | C9 H8 N4 O4 | SMILES: | O=C1N(C(=O)N(C=2NC(=O)C(=NC1=2)C=O)C)C | InChi: | InChI=1S/C9H8N4O4/c1-12-6-5(8(16)13(2)9(12)17)10-4(3-14)7(15)11-6/h3H,1-2H3,(H,11,15) | Definition date: | 2009-04-24 | Last modified: | 2024-09-27 | Identifier: | 1,3-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropteridine-6-carbaldehyde |
|
 | B5I | Name: | 2-propyl-L-norvaline | Formula: | C8 H17 N O2 | SMILES: | CCCC(N)(CCC)C(=O)O | InChi: | InChI=1S/C8H17NO2/c1-3-5-8(9,6-4-2)7(10)11/h3-6,9H2,1-2H3,(H,10,11) | Definition date: | 2022-09-21 | Last modified: | 2024-09-27 | Release date: | 2024-09-04 | Identifier: | 2-propyl-L-norvaline |
|
 | TW8 | Name: | 4-(3,4-dihydro-2~{H}-quinoxalin-1-ylsulfonyl)benzaldehyde | Formula: | C15 H14 N2 O3 S | SMILES: | O=Cc1ccc(cc1)[S](=O)(=O)N2CCNc3ccccc23 | InChi: | InChI=1S/C15H14N2O3S/c18-11-12-5-7-13(8-6-12)21(19,20)17-10-9-16-14-3-1-2-4-15(14)17/h1-8,11,16H,9-10H2 | Definition date: | 2021-01-14 | Last modified: | 2024-09-27 | Release date: | 2021-09-15 | Identifier: | 4-(3,4-dihydro-2~{H}-quinoxalin-1-ylsulfonyl)benzaldehyde |
|
 | TWE | Name: | 1-(4-methanoylphenyl)carbonylpiperidine-4-carbonitrile | Formula: | C14 H14 N2 O2 | SMILES: | O=Cc1ccc(cc1)C(=O)N2CCC(CC2)C#N | InChi: | InChI=1S/C14H14N2O2/c15-9-11-5-7-16(8-6-11)14(18)13-3-1-12(10-17)2-4-13/h1-4,10-11H,5-8H2 | Definition date: | 2021-01-14 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 1-(4-methanoylphenyl)carbonylpiperidine-4-carbonitrile |
|
 | TWQ | Name: | 3-[(3~{S})-3-methoxypiperidin-1-yl]-4-nitro-benzaldehyde | Formula: | C13 H16 N2 O4 | SMILES: | CO[CH]1CCCN(C1)c2cc(C=O)ccc2[N](=O)=O | InChi: | InChI=1S/C13H16N2O4/c1-19-11-3-2-6-14(8-11)13-7-10(9-16)4-5-12(13)15(17)18/h4-5,7,9,11H,2-3,6,8H2,1H3/t11-/m0/s1 | Definition date: | 2021-01-14 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 3-[(3~{S})-3-methoxypiperidin-1-yl]-4-nitro-benzaldehyde |
|
 | TWZ | Name: | ExoSTWZ molecular tweezer | Formula: | C48 H39 N3 O10 P2 | SMILES: | OC(=O)Cn1cc(CCO[P](O)(=O)Oc2c3[CH]4C[CH](c5cc6[CH]7C[CH](c8ccccc78)c6cc45)c3c(O[P](O)(O)=O)c9[CH]%10C[CH](c%11cc%12[CH]%13C[CH](c%14ccccc%13%14)c%12cc%10%11)c29)nn1 | InChi: | InChI=1S/C48H39N3O10P2/c52-42(53)20-51-19-21(49-50-51)9-10-59-63(57,58)61-48-45-40-17-38(34-13-30-26-11-28(32(30)15-36(34)40)24-7-3-1-5-22(24)26)43(45)47(60-62(54,55)56)44-39-18-41(46(44)48)37-16-33-29-12-27(31(33)14-35(37)39)23-6-2-4-8-25(23)29/h1-8,13-16,19,26-29,38-41H,9-12,17-18,20H2,(H,52,53)(H,57,58)(H2,54,55,56)/t26-,27+,28+,29-,38-,39+,40+,41- | Definition date: | 2020-03-02 | Last modified: | 2024-09-27 | Release date: | 2021-03-31 |
|
 | B6D | Name: | 2,4-bisacetamido-2,4,6-trideoxy-beta-D-glucopyranose | Formula: | C10 H18 N2 O5 | SMILES: | O=C(NC1C(OC(O)C(NC(=O)C)C1O)C)C | InChi: | InChI=1S/C10H18N2O5/c1-4-7(11-5(2)13)9(15)8(10(16)17-4)12-6(3)14/h4,7-10,15-16H,1-3H3,(H,11,13)(H,12,14)/t4-,7-,8-,9+,10-/m1/s1 | Synonyms: | 2,4-bis(acetylamino)-2,4,6-trideoxy-beta-D-glucopyranose | Definition date: | 2008-05-01 | Last modified: | 2024-09-27 | Identifier: | 2,4-bis(acetylamino)-2,4,6-trideoxy-beta-D-glucopyranose |
|
 | TX2 | Name: | 5'-O-{(R)-hydroxy[(2-sulfanylethyl)amino]phosphoryl}thymidine | Formula: | C12 H20 N3 O7 P S | SMILES: | O=P(O)(OCC2OC(N1C(=O)NC(=O)C(=C1)C)CC2O)NCCS | InChi: | InChI=1S/C12H20N3O7PS/c1-7-5-15(12(18)14-11(7)17)10-4-8(16)9(22-10)6-21-23(19,20)13-2-3-24/h5,8-10,16,24H,2-4,6H2,1H3,(H2,13,19,20)(H,14,17,18)/t8-,9+,10+/m0/s1 | Definition date: | 2009-10-01 | Last modified: | 2024-09-27 | Identifier: | 5'-O-{(R)-hydroxy[(2-sulfanylethyl)amino]phosphoryl}thymidine |
|
 | TX6 | Name: | (6aS,7S,10aS)-8-hydroxy-4-methoxy-2,7,10a-trimethyl-5,6,6a,7,10,10a-hexahydrobenzo[h]quinazoline-9-carbonitrile | Formula: | C17 H21 N3 O2 | SMILES: | N#CC1=C(C(C3C(C1)(C)c2nc(C)nc(c2CC3)OC)C)O | InChi: | InChI=1S/C17H21N3O2/c1-9-13-6-5-12-15(19-10(2)20-16(12)22-4)17(13,3)7-11(8-18)14(9)21/h9,13,21H,5-7H2,1-4H3/t9-,13-,17-/m0/s1 | Definition date: | 2015-08-20 | Last modified: | 2024-09-27 | Release date: | 2016-08-10 | Identifier: | (6aS,7S,10aS)-8-hydroxy-4-methoxy-2,7,10a-trimethyl-5,6,6a,7,10,10a-hexahydrobenzo[h]quinazoline-9-carbonitrile |
|
 | TXH | Name: | ~{tert}-butyl ~{N}-[(2~{S})-3-(1~{H}-indol-3-yl)-1-(2-methanoylhydrazinyl)-1-oxidanylidene-propan-2-yl]carbamate | Formula: | C17 H22 N4 O4 | SMILES: | CC(C)(C)OC(=O)N[CH](Cc1c[nH]c2ccccc12)C(=O)NNC=O | InChi: | InChI=1S/C17H22N4O4/c1-17(2,3)25-16(24)20-14(15(23)21-19-10-22)8-11-9-18-13-7-5-4-6-12(11)13/h4-7,9-10,14,18H,8H2,1-3H3,(H,19,22)(H,20,24)(H,21,23)/t14-/m0/s1 | Definition date: | 2023-01-13 | Last modified: | 2024-09-27 | Release date: | 2023-01-25 | Identifier: | ~{tert}-butyl ~{N}-[(2~{S})-3-(1~{H}-indol-3-yl)-1-(2-methanoylhydrazinyl)-1-oxidanylidene-propan-2-yl]carbamate |
|
 | TXI | Name: | (2R)-N-(4-chloro-3-oxobutyl)-2,4-dihydroxy-3,3-dimethylbutanamide | Formula: | C10 H18 Cl N O4 | SMILES: | O=C(NCCC(=O)CCl)C(O)C(C)(C)CO | InChi: | InChI=1S/C10H18ClNO4/c1-10(2,6-13)8(15)9(16)12-4-3-7(14)5-11/h8,13,15H,3-6H2,1-2H3,(H,12,16)/t8-/m0/s1 | Definition date: | 2011-09-06 | Last modified: | 2024-09-27 | Identifier: | (2R)-N-(4-chloro-3-oxobutyl)-2,4-dihydroxy-3,3-dimethylbutanamide |
|
 | B6Y | Name: | (1R,2S)-2-{[N-({[1-(tert-butoxycarbonyl)-4-ethylpiperidin-4-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C26 H46 N4 O10 S | SMILES: | C(=O)(NC(C(=O)NC(CC1CCNC1=O)C(S(=O)(=O)O)O)CC(C)C)OC2(CCN(CC2)C(=O)OC(C)(C)C)CC | InChi: | InChI=1S/C26H46N4O10S/c1-7-26(9-12-30(13-10-26)24(35)40-25(4,5)6)39-23(34)29-18(14-16(2)3)21(32)28-19(22(33)41(36,37)38)15-17-8-11-27-20(17)31/h16-19,22,33H,7-15H2,1-6H3,(H,27,31)(H,28,32)(H,29,34)(H,36,37,38)/t17-,18-,19-,22+/m0/s1 | Synonyms: | bound form | Definition date: | 2017-08-02 | Last modified: | 2024-09-27 | Release date: | 2018-04-04 | Identifier: | (1R,2S)-2-{[N-({[1-(tert-butoxycarbonyl)-4-ethylpiperidin-4-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | B77 | Name: | 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine | Formula: | C14 H15 N O2 | SMILES: | O(c1cc(ccc1OC)C)Cc2ncccc2 | InChi: | InChI=1S/C14H15NO2/c1-11-6-7-13(16-2)14(9-11)17-10-12-5-3-4-8-15-12/h3-9H,10H2,1-2H3 | Definition date: | 2009-07-21 | Last modified: | 2024-09-27 | Identifier: | 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine |
|
 | B78 | Name: | 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine | Formula: | C14 H15 N O2 | SMILES: | O(c1cc(OC)ccc1C)Cc2ccncc2 | InChi: | InChI=1S/C14H15NO2/c1-11-3-4-13(16-2)9-14(11)17-10-12-5-7-15-8-6-12/h3-9H,10H2,1-2H3 | Definition date: | 2009-07-21 | Last modified: | 2024-09-27 | Identifier: | 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine |
|
 | TXY | Name: | 3-[(5S)-4,5-dihydroxycyclohexa-1,3-dien-1-yl]-L-alanine | Formula: | C9 H13 N O4 | SMILES: | O=C(O)C(N)CC1=CC=C(O)C(O)C1 | InChi: | InChI=1S/C9H13NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,6,8,11-12H,3-4,10H2,(H,13,14)/t6-,8-/m0/s1 | Definition date: | 2013-05-27 | Last modified: | 2024-09-27 | Release date: | 2014-06-25 | Identifier: | 3-[(5S)-4,5-dihydroxycyclohexa-1,3-dien-1-yl]-L-alanine |
|
 | TY1 | Name: | O-tert-butyl-L-tyrosine | Formula: | C13 H19 N O3 | SMILES: | O=C(O)C(N)Cc1ccc(OC(C)(C)C)cc1 | InChi: | InChI=1S/C13H19NO3/c1-13(2,3)17-10-6-4-9(5-7-10)8-11(14)12(15)16/h4-7,11H,8,14H2,1-3H3,(H,15,16)/t11-/m0/s1 | Definition date: | 2010-10-06 | Last modified: | 2024-09-27 | Identifier: | O-tert-butyl-L-tyrosine |
|
 | TY2 | Name: | 3-AMINO-L-TYROSINE | Formula: | C9 H12 N2 O3 | SMILES: | O=C(O)C(N)Cc1ccc(O)c(N)c1 | InChi: | InChI=1S/C9H12N2O3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,10-11H2,(H,13,14)/t7-/m0/s1 | Definition date: | 2007-11-17 | Last modified: | 2024-09-27 | Identifier: | 3-amino-L-tyrosine |
|
 | TY5 | Name: | O-benzyl-L-tyrosine | Formula: | C16 H17 N O3 | SMILES: | O=C(O)C(N)Cc2ccc(OCc1ccccc1)cc2 | InChi: | InChI=1S/C16H17NO3/c17-15(16(18)19)10-12-6-8-14(9-7-12)20-11-13-4-2-1-3-5-13/h1-9,15H,10-11,17H2,(H,18,19)/t15-/m0/s1 | Definition date: | 2010-12-10 | Last modified: | 2024-09-27 | Identifier: | O-benzyl-L-tyrosine |
|